Retail Pharmacy in Brazil Current Behavior Changes Analysis¶
Ongoing Behavior Changes¶
The Brazilian retail pharmacy value chain is currently being shaped by several ongoing behavior changes among its final customers and participants. These changes are influencing relationships and demand dynamics across the Manufacturing, Distribution, and Retail stages.
One significant behavior change among end consumers (B2C) is the increasing adoption of omnichannel purchasing habits. Consumers are no longer solely relying on physical stores but are actively utilizing e-commerce platforms, mobile applications, and delivery services offered by pharmacies, particularly the larger chains. This behavior shift is driven by a desire for convenience and accessibility, allowing consumers to purchase medications and other products from anywhere and receive them quickly. [Retail Pharmacy in Brazil Final Customers Identification] The expansion of the retail footprint, with an average of 22 new pharmacies opening daily in 2024 and the total number reaching 93.7 thousand by the end of 2024, also reflects and caters to the growing consumer demand for physical proximity and convenience. [Current Demand Behavior Analysis]
Another evolving consumer behavior is the increased utilization of pharmacies for basic health services. Beyond purchasing products, consumers are seeking out pharmacies for services like vaccinations, blood pressure monitoring, glucose testing, and rapid diagnostic tests. [Value Chain Analysis] This indicates a growing trust in pharmacies as accessible points for primary health attention and a willingness to engage with them as more than just retail outlets for medication.
The market data reflects a continued growth in overall consumer spending and purchase volume. Total retail sales reached R$ 158.4 billion in 2024, an 11% increase, and units sold grew by 6.1% to 8.1 billion. [Current Demand Behavior Analysis] This demonstrates robust demand from the B2C segment, indicating not only more transactions but potentially an expanding customer base or increased purchasing frequency per customer.
Within the retail segment, a key trend impacting relationships and demand is the increasing consolidation and market share capture by large pharmacy chains. While the market still features a large number of independent pharmacies, major chains like RD Saúde, Grupo DPSP, and Farmácias Pague Menos are dominating in terms of revenue and medication dispensations. [Value Chain Analysis, Current Demand Behavior Analysis] These large players influence consumer behavior through aggressive pricing strategies, loyalty programs, and significant investments in technology and service expansion, drawing demand away from smaller competitors.
For B2B customers, particularly the public sector, the behavior remains largely consistent with reliance on large-scale procurement through tenders for the Unified Health System (SUS) and Farmácia Popular programs. [Value Chain Analysis, Retail Pharmacy in Brazil Final Customers Identification] This stable demand channel continues to be a significant factor for manufacturers and distributors, although the specifics of pricing and terms are dictated by public policy and procurement processes. Institutional clients like hospitals and clinics also maintain their behavior of procuring pharmaceuticals in bulk, often requiring specialized distribution services.
These behavior changes collectively highlight a market where end consumers are becoming more discerning, digitally connected, and expectant of convenience and integrated health services. The retail landscape is responding with expansion and service diversification, while the B2B segment continues its established procurement practices, albeit within a dynamic overall market context.
Table of the impact of these changes on the value chain:
| Behavior Change | Impact on Value Chain Relationships | Impact on Value Chain Demand |
|---|---|---|
| Consumer shift to Omnichannel | Strengthens retailer-consumer digital relationships; requires tighter integration and data sharing between retail and distribution. | Increases demand for online platforms, fast delivery services, and seamless integration of online and offline inventory. |
| Growing demand for Convenience/Accessibility | Puts pressure on distributors for faster and more flexible delivery options; strengthens retailer-consumer relationship through access. | Drives demand for more pharmacy locations, extended hours, and potentially smaller, more frequent deliveries from distribution. |
| Increased use of In-Pharmacy Health Services | Creates new service-based relationships between retailers and consumers; may lead to partnerships between retailers and service providers. | Generates new demand streams for health services provided within the pharmacy setting, supplementing product demand. |
| Growth in Overall Consumer Spending/Volume | Reinforces existing manufacturer-distributor and distributor-retailer relationships based on higher volume flow. | Increases overall volume and value of demand across the entire value chain (Manufacturing, Distribution, Retail). |
| Retail Market Consolidation by Large Chains | Shifts negotiation power towards large retailers in relationships with manufacturers and distributors; intensifies competition among retailers. | Concentrates consumer demand towards large chains, potentially reducing demand for independent pharmacies from manufacturers/distributors. |
| Increased Reliance on Distributors by Independents (Inferred) | Strengthens distributor-independent pharmacy relationships through crucial logistics and credit services. | Maintains a baseline demand from independent pharmacies for distribution services and product supply. |
| Public Sector Procurement (Stable B2B) | Maintains significant B2B relationships between manufacturers/distributors and government entities based on tender processes. | Provides a consistent and large-scale demand channel for specific pharmaceutical products within the public health system. |
References¶
Abradilan. Crescimento das grandes redes de farmácias. https://abradilan.com.br/crescimento-das-grandes-redes-de-farmacias/ Abradilan. Farmácias destacam-se entre 120 maiores varejistas do Brasil. https://abradilan.com.br/farmacias-destacam-se-entre-120-maiores-varejistas-do-Brasil/ Abradilan. Brasil tem 18 indústrias farmacêutica bilionárias. https://abradilan.com.br/brasil-tem-18-industrias-farmaceutica-bilionarias/ Abradilan. Das 20 maiores farmacêuticas do Brasil, 17 são nacionais. https://abradilan.com.br/das-20-maiores-farmaceuticas-do-brasil-17-so-nacionais/ Abradilan. Dez maiores farmacêuticas do Brasil detêm 48,6% das vendas. https://abradilan.com.br/dez-maiores-farmaceuticas-do-brasil-detem-486-das-vendas/ E-Commerce Brasil. Varejo farmacêutico brasileiro soma R$ 158,4 bi em 2024. https://web.archive.org/web/20240523095902/https://ecommercebrasil.com.br/noticias/varejo-farmaceutico-brasileiro-soma-r-158-4-bi-em-2024 Estadão RI. Principais redes de farmácias faturaram R$ 91,3 bi em 2023. https://web.archive.org/web/20240509012914/https://conteudo.estadao.com.br/system/public/estadaori/2024/04/29/principais-redes-de-farmacias-faturaram-r-913-bi-em-2023.html Giro News. Redes de farmácias faturaram R$ 91,3 bilhões em 2023; RD segue no topo do ranking. https://web.archive.org/web/20240520122416/https://gironews.com/farma-cosmeticos/redes-de-farmacias-faturaram-r-913-bilhoes-em-2023-rd-segue-no-topo-do-ranking/ InovaFarma. Confira os números atualizados do mercado de varejo farmacêutico no Brasil. https://web.archive.org/web/20240523095025/https://onovovarejo.com.br/inovafarma-numeros-atualizados-mercado-varejo-farmaceutico-brasil/ Investe SP. Brasil soma 47% do mercado farmacêutico na América Latina. https://web.archive.org/web/20240517191733/https://www.investe.sp.gov.br/noticia/brasil-soma-47-do-mercado-farmaceutico-na-america-latina Novo Varejo. Conheça as 5 maiores redes de farmácia do Brasil. https://web.archive.org/web/20240523100517/https://onovovarejo.com.br/5-maiores-redes-de-farmacia-brasil/ Panorama Farmacêutico. Ranking das grandes redes de farmácias da Abrafarma. https://web.archive.org/web/20240523094400/https://panoramafarmaceutico.com.br/ranking-grandes-redes-farmacias-abrafarma-2024/ Panorama Farmacêutico. Redes de farmácias mantêm projetos de expansão para 2024. https://web.archive.org/web/20240523095253/https://panoramafarmaceutico.com.br/redes-de-farmacias-mantem-projetos-de-expansao-para-2024/ Panorama Farmacêutico. Ranking das redes de farmácias mostra consolidação do setor. https://web.archive.org/web/20240523095536/https://panoramafarmaceutico.com.br/ranking-redes-de-farmacias-mostra-consolidação-do-setor/ Pague Menos tem receita bruta de R$3,1 bi no 1T24. https://web.archive.org/web/20240523100844/https://agenciabrasil.ebc.com.br/economia/noticia/2024-05/pague-menos-tem-receita-bruta-de-r31-bi-no-1t24